B-cell lymphoproliferation in chronic inflammatory rheumatic diseases

被引：0
|
作者：
Arne Hansen
Peter E Lipsky
Thomas Dörner
机构：
[1] both at the Charité University Hospital,A Hansen is Assistant Professor and Senior Physician at the Outpatients Department of Medicine, and T Dörner is Professor of Medicine in the Division of Clinical Hemostaseology
[2] Berlin,undefined
[3] Germany.,undefined
[4] PE Lipsky is the Editor-in-Chief of Nature Clinical Practice Rheumatology.,undefined
来源：
Nature Clinical Practice Rheumatology | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patients with chronic inflammatory rheumatic diseases, such as primary Sjögren's syndrome, systemic lupus erhythematosus and rheumatoid arthritis, are at higher risk of developing B-cell non-Hodgkin lymphomas compared with the general population. In their Review, Dr Hansen, Dr Lipsky and Dr Dörner discuss the risk of lymphoma, the common and disease-specific mechanisms of B-cell lymphoma development, and the clinical consequences in patients with inflammatory rheumatic diseases.
引用
收藏
页码：561 / 569
页数：8
相关论文
共 50 条
  • [1] B-cell lymphoproliferation in chronic inflammatory rheumatic diseases
    Hansen, Arne
    Lipsky, Peter E.
    Doerner, Thomas
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (10): : 561 - 569
  • [2] B-Cell Subset Differences in Inflammatory Rheumatic Diseases
    Gomes, Joao Lagoas
    Ligeiro, Dario
    Lima, Alice
    Teixeira, Cristina
    Sepriano, Alexandre
    Ramiro, Sofia
    Lopes, Carina
    Costa, Tiago
    Costa, Manuela
    Branco, Jaime Cunha
    Pimentel-Santos, Fernando
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] B-CELL SUBSETS DIFFERENCES IN INFLAMMATORY RHEUMATIC DISEASES
    Gomes, J. L.
    Ligeiro, D.
    Lima, A.
    Sepriano, A.
    Teixeira, C.
    Lopes, C.
    Costa, T.
    Ramiro, S.
    Mateus, M.
    Costa, M.
    Branco, J. C.
    Pimentel-Santos, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1052 - 1052
  • [4] POLYCLONAL B-CELL ACTIVATOR (PBA) IN RHEUMATIC DISEASES
    EISENBERG, GM
    LEE, TT
    SKOSEY, JL
    TEODORESCU, M
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (05): : 558 - 559
  • [5] B-cell targeted therapy for children and adolescents with rheumatic diseases
    Morbach, H.
    Girschick, H. J.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (04): : 347 - 353
  • [6] THE PRESENCE OF POLYCLONAL B-CELL ACTIVATOR IN A VARIETY OF RHEUMATIC DISEASES
    EISENBERG, G
    WAHI, R
    SKOSEY, JL
    TEODORESCU, M
    [J]. CLINICAL RESEARCH, 1981, 29 (04): : A723 - A723
  • [7] Novel B-cell directed strategies for the treatment of rheumatic diseases
    Tarner, I. H.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (05): : 380 - +
  • [8] POLYCLONAL B-CELL ACTIVATOR IN THE SERUM OF PATIENTS WITH RHEUMATIC DISEASES
    TEODORESCU, M
    CHANG, JL
    SKOSEY, JL
    [J]. CLINICAL RESEARCH, 1979, 27 (04): : A694 - A694
  • [9] PATTERNS OF B-CELL AND T-CELL GENE REARRANGEMENTS IN CHRONIC INFLAMMATORY DISEASES OF THE COLON
    TORLAKOVIC, E
    JESSURUN, J
    MCGLENNEN, R
    [J]. LABORATORY INVESTIGATION, 1994, 70 (01) : A68 - A68
  • [10] ABNORMALITIES OF B-CELL ACTIVATION AND IMMUNOREGULATION IN PATIENTS WITH CHRONIC INFLAMMATORY LIVER-DISEASES
    SIEBER, G
    TEICHMANN, JV
    MOLLER, B
    HOPF, U
    [J]. IMMUNOBIOLOGY, 1988, 178 (03) : 215 - 223
12345